Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti‐Tumour Potency on Prostate Cancer Cells
Paolo Fagone(University of Catania), Ferdinando Nicoletti(University of Catania), Marco Donia(University of Copenhagen), Marinella Coco(University of Catania), Santa Mammana(University of Catania), Katia Mangano(University of Catania), Cinzia Quattrocchi, James A. McCubrey(East Carolina University), Massimo Libra(University of Catania)
Cited by 25
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
|Frontiers in Pharmacology|2018|878
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508